Category Archives: Pr Newswire

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Aug. 16, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in […]

Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency

World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of international concern (PHEIC) 1 Tonix’s live virus vaccine candidate, TNX-801, is designed to provide long-term protection from mpox and smallpox with one dose TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with intratracheal monkeypox virus […]

Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026 Ongoing Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with over 30 clinical sites activated; Top-line results are expected by the second quarter of 2026 SGT-210 proof-of-concept study in patients suffering from Darier disease, a […]

SONGMICS HOME and Priceless Pets Rescue Team Up for “Lovely Adoption Saturday”

CHINO HILLS, Calif., Aug. 16, 2024 /PRNewswire/ — The global-leading online furnishings brand SONGMICS HOME has once again partnered with the non-profit animal welfare organization Priceless Pets Rescue to launch a new charitable event. United by a shared mission to enhance the lives of animals and their owners, this collaboration aims to bring attention to the […]

Lufax to Announce Second Quarter 2024 Financial Results on August 21, 2024

SHANGHAI, Aug. 16, 2024 /PRNewswire/ — Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it plans to release its second quarter 2024 financial results after the market closes on Wednesday, August 21, 2024, U.S. Eastern Time. The […]

WSPN Secures $30 Million in Seed Funding to Redefine the Future of Digital Payments with Stablecoin 2.0

SINGAPORE, Aug. 16, 2024 /PRNewswire/ — WSPN (Worldwide Stablecoin Payment Network), a leading provider of next-generation stablecoin infrastructure, has raised US$30 million in Seed funding round. This round was led by Folius Ventures and Foresight Venture, with participation from prominent investors including Hash Global, Generative Ventures, RedPoint Capital, and a consortium of top-tier investment companies, […]

Medtronic announces cash dividend for second quarter of fiscal year 2025

GALWAY, Ireland, Aug. 16, 2024 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 15, 2024, approved the company’s cash dividend for the second quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic […]

Noah to Report Second Quarter and Half Year 2024 Unaudited Financial Results on August 28, 2024

SHANGHAI, Aug. 16, 2024 /PRNewswire/ — Noah Holdings Limited (the “Company” or “Noah”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for Mandarin speaking high-net-worth investors, today announced that it will report its unaudited financial results for the second quarter and half […]

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

MELBOURNE, Australia, Aug. 15, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that our Chief Executive Officer, Steven Lydeamore has been invited to present at the Emerging Growth Conference on August 22nd, 2024. Immuron Limited invites individual and institutional investors as […]